Refeyn
Pre-clinicalDiscover how Refeyn's mass photometry technologies can rapidly characterize single particles - like proteins and viral vectors - in solution and without labels.
Founded
2018
Focus
DiagnosticsProteomics
About
Discover how Refeyn's mass photometry technologies can rapidly characterize single particles - like proteins and viral vectors - in solution and without labels.
Funding History
3Total raised: $64.5M
Series B$47MNorthpond VenturesJun 15, 2022
Series A$15MParkwalk AdvisorsJun 15, 2020
Seed$2.5MOxford Sciences InnovationJun 15, 2018
Company Info
TypePrivate
Founded2018
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile